DENND4B Inhibitors
DENND4B Inhibitors are a putative group of chemicals that impede the function of the DENND4B protein. DENND4B is part of the DENN (Differentially Expressed in Normal and Neoplastic cells) domain-containing family of proteins, which are known to be involved in the regulation of Rab GTPases, key regulators of intracellular vesicle trafficking. The function of DENND4B, specifically, is associated with the activation of certain Rab GTPases by catalyzing the exchange of GDP for GTP. Inhibitors of DENND4B disrupt this guanine nucleotide exchange factor (GEF) activity, thereby affecting the trafficking pathways that are essential for various cellular processes. The inhibition might be achieved through direct interaction with the DENND4B protein, blocking its GEF domain and preventing the exchange of GDP to GTP on the target Rab GTPases, or by interfering with its ability to localize to specific membranes where it exerts its action.
Structural studies could elucidate the precise binding mode of inhibitors with DENND4B, detailing the molecular interactions responsible for the observed inhibition. These studies would help in understanding the structure-activity relationship. The exploration of DENND4B Inhibitors contributes to a greater comprehension of vesicle trafficking and its regulation by Rab GTPases. By selectively modulating the activity of DENND4B, researchers could investigate the specific pathways and cellular functions that are regulated by this GEF. Such inhibitors might also serve as valuable probes to decipher the complex network of vesicular transport within cells, revealing how intracellular signaling, nutrient uptake, and waste removal are coordinated. The study of these inhibitors could provide insights into the fundamental mechanisms of membrane dynamics and the role of GEFs like DENND4B in orchestrating these processes. Understanding the impact of DENND4B inhibition on cellular functions could also enhance knowledge in the field of cell biology, particularly in the context of vesicle formation, trafficking, and fusion.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an MEK inhibitor that interferes with the MAPK/ERK pathway. By inhibiting MEK, this compound prevents the activation of ERK, which would otherwise promote the endocytosis and trafficking of membrane proteins, a process where DENND4B is speculated to play a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a PI3K inhibitor that diminishes the PI3K/Akt signaling pathway. DENND4B, being associated with membrane trafficking, may be indirectly inhibited due to reduced PI3K activity leading to altered membrane dynamics and vesicle trafficking. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor that robustly diminishes the PI3K/Akt pathway. Similar to LY294002, the inhibition of PI3K impairs various cellular processes including those that might involve DENND4B’s function in vesicular trafficking. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that suppresses the mTORC1 pathway, which is crucial for vesicle formation and protein trafficking. By inhibiting mTOR, rapamycin might diminish DENND4B function indirectly as mTORC1 signaling is essential for vesicle trafficking. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor. By inhibiting a variety of kinases, it can interfere with multiple signaling pathways that may indirectly lead to the functional inhibition of DENND4B, particularly through altered vesicular dynamics. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is an inhibitor of ADP-ribosylation factor (ARF), which is a small GTPase involved in vesicle formation. By inhibiting ARF, Brefeldin A disrupts vesicular trafficking, potentially hindering DENND4B’s role in this process. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a GTPase inhibitor that targets dynamin, involved in vesicle scission. By inhibiting dynamin, Dynasore could indirectly decrease the functional activity of DENND4B by impeding the endocytic process and vesicular trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug known to inhibit clathrin-dependent endocytosis. By impairing this pathway, the functional activity of DENND4B could be indirectly diminished as it may be involved in the clathrin-mediated endocytic trafficking of proteins. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can hinder tyrosine phosphorylation-dependent signaling pathways. These pathways are often involved in the regulation of vesicle formation and trafficking, processes that could involve DENND4B function. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $105.00 $299.00 $474.00 | 15 | |
Gö 6983 is a potent protein kinase C (PKC) inhibitor. Since PKC is involved in a variety of cellular processes including vesicle formation and trafficking, inhibition of PKC by Gö 6983 might indirectly diminish DENND4B's role in these processes. | ||||||